Invention Grant
- Patent Title: Hepatitis C virus inhibitors
- Patent Title (中): 丙型肝炎病毒抑制剂
-
Application No.: US13152377Application Date: 2011-06-03
-
Publication No.: US08778938B2Publication Date: 2014-07-15
- Inventor: Yao-Ling Qiu , Ce Wang , Hui Cao , Xiaowen Peng , Datong Tang , Yat Sun Or
- Applicant: Yao-Ling Qiu , Ce Wang , Hui Cao , Xiaowen Peng , Datong Tang , Yat Sun Or
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Roy P. Issac, Esq.; Carolyn S. Elmore, Esq.
- Main IPC: A61K31/397
- IPC: A61K31/397 ; A61K31/5377 ; A61K31/495 ; A61K31/506 ; A61K31/443 ; A61K31/4525 ; A61K31/47 ; A61K31/41 ; A61K31/4178 ; A61K31/4196 ; A61K31/422 ; A61K31/42 ; A61K31/4245 ; A61K31/427 ; A61K31/428 ; C07D273/01 ; C07D239/24 ; C07D241/04 ; C07D221/20 ; C07D277/60 ; C07D277/20 ; C07D263/02 ; C07D263/30 ; C07D261/20 ; C07D257/02 ; C07D233/54
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the Hepatitis C Virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the Hepatitis C Virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20110300104A1 HEPATITIS C VIRUS INHIBITORS Public/Granted day:2011-12-08
Information query
